Bajaj Healthcare enters into API development and supply agreement with European company
Bajaj Healthcare has entered into a development and supply agreement for an Active Pharmaceutical Ingredient (API) with a European entity. This API after its development will be initially supplied in small quantities and will be used by the EU partner to carry out clinical trials for an alternative indication.
Based on the outcome of these trials, the supplies will be done from the Company's FDA approved manufacturing facility situated at Savli, Vadodara.
History of Stock Market Crashes
8 mins read . Oct 17, 2024
History of ITC Group
10 mins read . Oct 16, 2024
Public Sector Undertakings in India
9 mins read . Oct 11, 2024